Supporting Your Immune Response
The probiotic strain AB21 is the first clinically validated for the treatment of Covid-19.
A Study including 300 non-hospitalized adult participants with PCR-confirmed COVID-19 and mild symptoms:
Remission rate, as measured by both the absence of COVID-19 symptoms and a negative RT-PCR test.
Reduction in the number of symptomatic patients with COVID-19.
Reduction in the duration of specific symptoms.
Reduced viral load in nasopharyngeal swabs.
Increased specific IgG and IgM levels against SARS-CoV-2.
The study is currently awaiting peer review.
More Info Coming Soon
Keep up to date with the latest news, clinically studies and product release date.